Alcaine ™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5%

Manufacturer
Alcon Laboratories, Inc. | Alcon Research, LLC
Effective date
2026-06-10
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
12
Source
monthly-update
Hydrated at
2026-07-17 21:39:08

Label at a glance#

ProductAlcaine
Active ingredientPROPARACAINE HYDROCHLORIDE
Label structure13 sections

Indications and uses

ALCAINE™ ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.

Dosage and administration

Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating. Short Corneal and Conjunctival Procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses. NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color. If the solution becomes darker, discard the solution.

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is a topical local anesthetic for ophthalmic use. The active ingredient is represented by the structural formula:

chemical
chemical

Established Name: Proparacaine Hydrochloride
Chemical Name: Benzoic acid, 3-amino-4-propoxy-,2-(diethylamino) ethyl ester, monohydrochloride.
Molecular Weight: 330.85 g/mol

Each mL contains of ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5%:
Active:
proparacaine hydrochloride 5 mg 0.5%. Preservative: benzalkonium chloride (0.01%).
Inactives: glycerin and purified water. The pH may be adjusted with hydrochloric acid and/or sodium hydroxide.

CLINICAL PHARMACOLOGY:

CLINICAL PHARMACOLOGY SECTION

ALCAINE™ ophthalmic solution is a rapidly-acting topical anesthetic, with induced anesthesia lasting approximately 10-20 minutes.

INDICATIONS AND USAGE:

INDICATIONS & USAGE SECTION

ALCAINE™ ophthalmic solution is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g. tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

ALCAINE™ ophthalmic solution should be considered contraindicated in patients with known hypersensitivity to any of the ingredients of this preparation.

WARNINGS:

WARNINGS SECTION

NOT FOR INJECTION - FOR TOPICAL OPHTHALMIC USE ONLY. Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.

ALCAINE™ ophthalmic solution is indicated for administration under the direct supervision of a healthcare provider. ALCAINE™ ophthalmic solution is not intended for patient self-administration.

PRECAUTIONS:

PRECAUTIONS SECTION

Carcinogenesis, Mutagenesis, Impairment of Fertility.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential, mutagenicity, or possible impairment of fertility in males or females.

Pregnancy:

PREGNANCY SECTION

Animal reproduction studies have not been conducted with ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5%. It is also not known whether proparacaine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine hydrochloride should be administered to a pregnant woman only if clearly needed.

Nursing Mothers:

NURSING MOTHERS SECTION

It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when proparacaine hydrochloride is administered to a nursing woman.

Pediatric Use:

PEDIATRIC USE SECTION

Safety and effectiveness of proparacaine hydrochloride ophthalmic solution in pediatric patients have been established. Use of proparacaine hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.

Geriatric Use:

GERIATRIC USE SECTION

No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.

ADVERSE REACTIONS:

ADVERSE REACTIONS SECTION

Occasional temporary stinging, burning and conjunctival redness may occur with the use of proparacaine. Corneal edema has been reported following the use of proparacaine. A rare, severe, immediate-type, apparently hyperallergic corneal reaction characterized by acute, intense and diffuse epithelial keratitis, a gray, ground glass appearance, sloughing of large areas of necrotic epithelium, corneal filaments and, sometimes, iritis with descemetitis has been reported.

Allergic contact dermatitis from proparacaine with drying and fissuring of the fingertips has also been reported.

DOSAGE AND ADMINISTRATION:

DOSAGE & ADMINISTRATION SECTION

Usual Dosage: Removal of foreign bodies and sutures, and for tonometry: 1 to 2 drops (in single instillations) in each eye before operating.

Short Corneal and Conjunctival Procedures: 1 drop in each eye every 5 to 10 minutes for 5 to 7 doses.

NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color. If the solution becomes darker, discard the solution.

HOW SUPPLIED:

HOW SUPPLIED SECTION

ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% is supplied in DROP-TAINER® dispensers as follows:

15 mL                NDC 0998-0016-15

Storage:

Bottle must be stored in unit carton to protect contents from light.
Store bottles under refrigeration at 2°C to 8°C (36°F to 46°F).

After opening, ALCAINE™ can be used until the expiration date on the bottle.

NOTE: ALCAINE™ (proparacaine hydrochloride ophthalmic solution, USP) 0.5% should be clear to straw-color. If the solution becomes darker, discard the solution.

Distributed by:
ALCON LABORATORIES, INC.
Fort Worth, Texas 76134

Revised: 06/2024


Alcon
Alcon Laboratories, Inc.
6201 South Freeway
Fort Worth, Texas 76134 USA

© 2024 Alcon Inc.
Printed in USA
alcon.medinfo@alcon.com
1-800-757-9195  


300063110-0723

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0998-0016-15

Alcon

Alcaine™
(proparacaine hydrochloride ophthalmic solution USP) 0.5%

15 mL   Sterile

Rx Only

PRECAUTION:
NOT FOR INJECTION. FOR TOPICAL OPHTHALMIC USE ONLY. Do not touch dropper tip to any surface, as this may contaminate the solution.

USUAL DOSAGE: 1 or 2 drops. Read enclosed insert.

Bottles must be stored in unit carton to protect from light.

STORAGE: Store between 2º to 8ºC (36º to 46ºF). After opening, ALCAINE™ can be used until the expiration date on the bottle.

ALCAINE™ (proparacaine hydrochloride ophthalmic solution) should be clear to straw-color. If the solution becomes darker, discard the solution.

INGREDIENTS: Each mL contains: Active: proparacaine hydrochloride 5 mg (0.5%). Preservative: benzalkonium chloride 0.01%. Inactives: glycerin, hydrochloric acid and/or sodium hydroxide (to adjust pH), purified water

pH range 4.0 to 6.0

1-800-757-9195
alcon.medinfo@alcon.com
Country of Origin: Switzerland

Alcon
ALCON LABORATORIES, INC.
6201 South Freeway
Fort Worth, Texas 76134 USA     
Printed in USA
300056033-0922

Carton Label
Carton Label

NDC 0998-0016-15

Alcon

Alcaine™
(proparacaine hydrochloride ophthalmic solution USP) 0.5%

Sterile 15 mL

Rx Only

PRECAUTION:
NOT FOR INJECTION. FOR TOPICAL OPHTHALMIC USE ONLY. Do not touch dropper tip to any surface as this may contaminate the solution.

USUAL DOSAGE: 1 or 2 drops. Read enclosed insert.

STORAGE: Store between 2º to 8ºC (36º to 46ºF).
After opening, ALCAINE™ can be used until the expiration date on the bottle.

Bottles must be stored in unit carton to protect from light.

ALCAINE™ (proparacaine hydrochloride ophthalmic solution) should be clear to straw-color. If the solution becomes darker, discard the solution.


INGREDIENTS: Each mL contains: Active: proparacaine hydrochloride 5 mg (0.5%).


ALCON LABORATORIES, INC.
Fort Worth, Texas 76134 USA     Printed in USA

LOT/EXP.:

Container Label
Container Label

  

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeDataBar Limited(01)00309980016156GTIN-14: 00309980016156
GTIN-12: 309980016156
UPC-A: 309980016156
EAN-13: 0309980016156
GTIN storage (14 digits): 00309980016156
container15ml.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
9ba0893a-4390-4124-b66b-ffd4f2b29a0eProduct name220260305

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0998-0016-15ML - Milliliter0998-0016a138be10-e9e1-4c7a-b2a9-05cdfaeb1f0612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PROPARACAINE HYDROCHLORIDEACTIVE INGREDIENTU96OL57GOY2
PROPARACAINEACTIVE MOIETYB4OB0JHI1X2
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W72
GLYCERININACTIVE INGREDIENTPDC6A3C0OX2
HYDROCHLORIC ACIDINACTIVE INGREDIENTQTT17582CB2
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
0998-00160998-0016-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
112024-07-17full-release2026-05-31 21:08:30

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 8 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
GLYCERINGLYCERINPDC6A3C0OXSOLUTION/ DROPS / OPHTHALMIC12 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates
HYDROCHLORIC ACIDHYDROCHLORIC ACIDQTT17582CBSOLUTION/ DROPS / OPHTHALMICADJ PHExact identifier — unii+route+dosage form
2 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A080027-001ALCAINEPROPARACAINE HYDROCHLORIDE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A080027-001AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198284e616aacf4f…
2026-08-18 06:07:402026-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198231067a03dcf5…
2025-08-23 18:47 UTC2025-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19826a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19822680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 19823a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080027-001ALCAINE0.5%SOLUTION/DROPS / OPHTHALMICATApproved before 1982f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A080027-001AT184e616aacf4f…
2026-08-18 06:07:402026-07A080027-001AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A080027-001AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A080027-001AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08A080027-001AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A080027-001AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A080027-001AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A080027-001AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A080027-001AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A080027-001AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A080027-001AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A080027-001AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A080027-001AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A080027-001AT1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A080027-001AT11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A080027-001AT18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A080027-001AT15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A080027-001AT15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A080027-001AT14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A080027-001AT174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A080027-001AT1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A080027-001AT1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A080027-001AT187673890dc5c…
2021-03-12 10:30 UTC2021-03A080027-001AT15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A080027-001AT18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A080027-001AT1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A080027-001AT13f01610625f2…
2019-09-15 20:21 UTC2019-09A080027-001AT1b00525d2431f…
2019-07-19 19:46 UTC2019-07A080027-001AT1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A080027-001AT16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A080027-001AT11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A080027-001AT1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A080027-001AT1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A080027-001AT19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A080027-001AT1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A080027-001AT13f0d92c62455…
2023-05-13 08:27 UTC2023-05A080027-001AT1053a50430f4f…
2023-01-26 05:58 UTC2023-01A080027-001AT13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A080027-001AT13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A080027-001AT1f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AlcainePROPARACAINE HYDROCHLORIDEAlcon Laboratories, Inc.0c0fa0bf-977d-4539-b8dc-54c187c5b0942026-06-10Warnings, Adverse reactionsExact identifier
ndc (package): 0998-0016-15
ndc (product): 0998-0016
ndc11 (package): 00998001615
spl id: 2060dc26-3548-4b86-900c-ef53b5f453a2
spl set id: 0c0fa0bf-977d-4539-b8dc-54c187c5b094

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.